Fluorescein ( DrugBank: Fluorescein )

3 diseases

19. ライソゾーム病

臨床試験数 : 854 / 薬物数 : 716 - (DrugBank : 105) / 標的遺伝子数 : 70 - 標的パスウェイ数 : 191

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01165697 (ClinicalTrials.gov)	July 2010	16/7/2010	Establishment of Biomarkers for Fabry Disease	Establishment of Biomarkers for Fabry Disease	Fabry Disease	Other: Fluorescein angiography	Ohio State University	Genzyme, a Sanofi Company	Completed	18 Years	N/A	All	4	N/A	United States

臨床試験数 : 14 / 薬物数 : 21 - (DrugBank : 14) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 44

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCTs031200402	23/04/2021	08/03/2021	Search for abnormalities of fundus blood vessels in moyamoya disease	Search for abnormalities of fundus blood vessels in moyamoya disease	Moyamoya disease Moyamoya disease	For fluorescein fundus angiography, 500 mg of fluorescein (5 ml vial of aqueous solution containing 500 mg of fluorescein) and 25 mg of Ophthagreen (2 ml of blue indocyanine green) are dissolved in 2 ml of distilled water for injection and injected through the forearm of the elbow vein. In daily practice, diabetic retinopathy can be treated by using a diabetic retinal imaging system (optos). In daily practice, it is used for the diagnosis of diabetic retinopathy, uveitis, occlusive retinal vascular disease, and age-related macular degeneration.	Akiyama Hideo	NULL	Recruiting	>= 20age old	Not applicable	Both	50	N/A	Japan

臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCTs041180035	15/12/2017	31/01/2019	Dual center study of pCLE for UCAN	Dual center study of usefulness of probe-based confocal laser endomicroscopy for suspected ulcerative colitis-associated neoplasia	suspected ulcerative colitis-associated neoplasia	pCLE after intravenous administration of fluorescein	Ohmiya Naoki	NULL	Recruiting	>= 20age old	< 80age old	Both	30	N/A	Japan
2	JPRN-UMIN000032250	2017/12/15	14/04/2018	Dual center study of usefulness of probe-based confocal laser endomicroscopy for suspected ulcerative colitis-associated neoplasia	Dual center study of usefulness of probe-based confocal laser endomicroscopy for suspected ulcerative colitis-associated neoplasia - Dual center study of pCLE for UCAN	suspected ulcerative colitis-associated neoplasia	pCLE after intravenous administration of fluorescein	Fujita Health University School of Medicine, Department of Gastroenterology	Center for Diagnostic and Therapeutic Endoscopy, School of Medicine KeioUniversity	Recruiting	20years-old	85years-old	Male and Female	40	Not applicable	Japan